Award
National Cancer Institute 5R21CA288928-02
Mechanisms of Th17-DC immunotherapy for ovarian cancer
Recipient
UNIV OF ARKANSAS FOR MED SCIS
Award Amount
$178,819.00
Ceiling
$178,819.00
Awarded
February 14, 2025
Identifier
5R21CA288928-02
NIH-funded research project testing the efficacy of Th17-DC vaccination combined with anti-PD-1 therapy for ovarian cancer, emphasizing B cell responses and tertiary lymphoid structures.
Description
This project investigates the efficacy of Th17-inducing dendritic cell (Th17-DC) vaccination combined with anti-PD-1 therapy in ovarian cancer, focusing on the role of B cell responses and tertiary lymphoid structures in therapeutic outcomes.